132 related articles for article (PubMed ID: 7075120)
1. Furosemide disposition in cirrhosis.
Verbeeck RK; Patwardhan RV; Villeneuve JP; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1982 Jun; 31(6):719-25. PubMed ID: 7075120
[TBL] [Abstract][Full Text] [Related]
2. Furosemide kinetics and dynamics in patients with cirrhosis.
Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
[TBL] [Abstract][Full Text] [Related]
3. Furosemide kinetics in patients with hepatic cirrhosis with ascites.
Fuller R; Hoppel C; Ingalls ST
Clin Pharmacol Ther; 1981 Oct; 30(4):461-7. PubMed ID: 7285480
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of furosemide in patients with hepatic cirrhosis.
González G; Arancibia A; Rivas MI; Caro P; Antezana C
Eur J Clin Pharmacol; 1982; 22(4):315-20. PubMed ID: 7106167
[TBL] [Abstract][Full Text] [Related]
5. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.
Keller E; Hoppe-Seyler G; Mumm R; Schollmeyer P
Eur J Clin Pharmacol; 1981; 20(1):27-33. PubMed ID: 7308269
[TBL] [Abstract][Full Text] [Related]
6. Furosemide disposition in cirrhotic patients.
Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic disposition and protein binding of furosemide in newborn infants.
Aranda JV; Perez J; Sitar DS; Collinage J; Portuguez-Malavasi A; Duffy B; Dupont C
J Pediatr; 1978 Sep; 93(3):507-11. PubMed ID: 690779
[TBL] [Abstract][Full Text] [Related]
8. The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis.
Assy N; Kayal M; Mejirisky Y; Gorenberg M; Hussein O; Schlesinger S
BMC Gastroenterol; 2006 Nov; 6():39. PubMed ID: 17134488
[TBL] [Abstract][Full Text] [Related]
9. Altered disposition and availability of cimetidine in liver cirrhotic patients.
Gugler R; Müller-Liebenau B; Somogyi A
Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
[TBL] [Abstract][Full Text] [Related]
10. Elimination of furosemide in healthy subjects and in those with renal failure.
Beermann B; Dalén E; Lindström B
Clin Pharmacol Ther; 1977 Jul; 22(1):70-8. PubMed ID: 872498
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis.
Traeger A; Häntze R; Penzlin M; Krombholz B; Reinhardt M; Keil E; Jorke D
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):129-33. PubMed ID: 3997298
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of cimetidine on furosemide kinetics and dynamics in patients with hepatic cirrhosis.
Sanchis Closa A; Lambert C; du Souich P
Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):461-6. PubMed ID: 8225696
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics and diuretic effect of furosemide in plain tablet and retard capsule with normal subjects and cirrhotic patients.
Uchino K; Isozaki S; Amano J; Tanaka N; Saitoh Y; Nakagawa F; Tamura Z; Oka H
J Pharmacobiodyn; 1983 Sep; 6(9):684-91. PubMed ID: 6655548
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of furosemide in advanced renal failure.
Huang CM; Atkinson AJ; Levin M; Levin NW; Quintanilla A
Clin Pharmacol Ther; 1974 Oct; 16(4):659-66. PubMed ID: 4422027
[No Abstract] [Full Text] [Related]
15. Disposition and diuretic effect of furosemide in the nephrotic syndrome.
Keller E; Hoppe-Seyler G; Schollmeyer P
Clin Pharmacol Ther; 1982 Oct; 32(4):442-9. PubMed ID: 7116760
[TBL] [Abstract][Full Text] [Related]
16. Hydralazine and furosemide kinetics.
Nomura A; Yasuda H; Katoh K; Akimoto T; Miyazaki K; Arita T
Clin Pharmacol Ther; 1982 Sep; 32(3):303-6. PubMed ID: 7105621
[TBL] [Abstract][Full Text] [Related]
17. Population-based meta-analysis of furosemide pharmacokinetics.
Van Wart SA; Shoaf SE; Mallikaarjun S; Mager DE
Biopharm Drug Dispos; 2014 Mar; 35(2):119-33. PubMed ID: 24151207
[TBL] [Abstract][Full Text] [Related]
18. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.
Smith DE; Lin ET; Benet LZ
Drug Metab Dispos; 1980; 8(5):337-42. PubMed ID: 6107232
[TBL] [Abstract][Full Text] [Related]
19. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of furosemide in children with nephrotic syndrome.
González-Martín G; Bravo I; Ibarra N; Arancibia A
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):598-601. PubMed ID: 6668097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
